Sinsin Pharmaceutical Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Sinsin Pharmaceutical has a total shareholder equity of ₩64.1B and total debt of ₩44.4B, which brings its debt-to-equity ratio to 69.2%. Its total assets and total liabilities are ₩128.4B and ₩64.2B respectively. Sinsin Pharmaceutical's EBIT is ₩6.1B making its interest coverage ratio 3. It has cash and short-term investments of ₩790.2M.
Wichtige Informationen
69.2%
Verhältnis von Schulden zu Eigenkapital
₩44.39b
Verschuldung
| Zinsdeckungsgrad | 3x |
| Bargeld | ₩790.23m |
| Eigenkapital | ₩64.14b |
| Gesamtverbindlichkeiten | ₩64.24b |
| Gesamtvermögen | ₩128.38b |
Jüngste Berichte zur Finanzlage
Recent updates
What Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) 40% Share Price Gain Is Not Telling You
Jul 30
Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues
Mar 20What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?
Mar 06Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?
Feb 08
If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today
Jan 18We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability
Dec 25What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?
Nov 29Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: A002800's short term assets (₩52.3B) do not cover its short term liabilities (₩56.5B).
Langfristige Verbindlichkeiten: A002800's short term assets (₩52.3B) exceed its long term liabilities (₩7.8B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: A002800's net debt to equity ratio (68%) is considered high.
Schulden abbauen: A002800's debt to equity ratio has reduced from 85% to 69.2% over the past 5 years.
Schuldendeckung: A002800's debt is not well covered by operating cash flow (7.8%).
Zinsdeckung: A002800's interest payments on its debt are well covered by EBIT (3x coverage).